Variant report
Variant | nsv889994 |
---|---|
Chromosome Location | chr8:5430301-5474720 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:5374260..5376916-chr8:5431835..5433649,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577387694 | chr8:5433232-5433233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74430642 | chr8:5433245-5433246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79762017 | chr8:5433249-5433250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544916632 | chr8:5433255-5433256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563200884 | chr8:5433269-5433270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183807267 | chr8:5433277-5433278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542251947 | chr8:5433287-5433288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568253709 | chr8:5433295-5433296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116402641 | chr8:5433336-5433337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528156885 | chr8:5433345-5433346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189596700 | chr8:5433349-5433350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10096145 | chr8:5433365-5433366 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs533526421 | chr8:5433384-5433385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374636432 | chr8:5433392-5433393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34040265 | chr8:5433402-5433403 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570364126 | chr8:5433406-5433407 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181644941 | chr8:5433423-5433424 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549093778 | chr8:5433424-5433425 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149740262 | chr8:5433430-5433431 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369514436 | chr8:5433439-5433440 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10105978 | chr8:5433456-5433457 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs553014688 | chr8:5433459-5433460 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565683630 | chr8:5433466-5433467 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145478879 | chr8:5433467-5433468 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534559257 | chr8:5433476-5433477 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186674731 | chr8:5433485-5433486 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554595912 | chr8:5433490-5433491 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116929259 | chr8:5433513-5433514 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10106095 | chr8:5433531-5433532 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs117820484 | chr8:5433541-5433542 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192032132 | chr8:5433549-5433550 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572765964 | chr8:5433553-5433554 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374664658 | chr8:5433570-5433571 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540341970 | chr8:5433576-5433577 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181904082 | chr8:5433623-5433624 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533616280 | chr8:5433630-5433631 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545609361 | chr8:5433631-5433632 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564044668 | chr8:5433645-5433646 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557570222 | chr8:5433653-5433654 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531091715 | chr8:5433663-5433664 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549625820 | chr8:5433688-5433689 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2733072 | chr8:5433699-5433700 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528426841 | chr8:5433703-5433704 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546692646 | chr8:5433705-5433706 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546500198 | chr8:5433725-5433726 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571404121 | chr8:5433742-5433743 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559576105 | chr8:5433817-5433818 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538483674 | chr8:5433820-5433821 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556719179 | chr8:5433862-5433863 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs80128294 | chr8:5433882-5433883 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5433200-5433800 | Enhancers | Brain Substantia Nigra | brain |
2 | chr8:5433400-5434000 | Active TSS | Brain Anterior Caudate | brain |
3 | chr8:5433600-5434000 | Enhancers | Brain Inferior Temporal Lobe | brain |
4 | chr8:5433800-5434200 | Weak transcription | Brain Substantia Nigra | brain |
5 | chr8:5434200-5435000 | Enhancers | Brain Substantia Nigra | brain |
6 | chr8:5449800-5450000 | ZNF genes & repeats | Pancreas | Pancrea |
7 | chr8:5449800-5450200 | Enhancers | Esophagus | oesophagus |
8 | chr8:5449800-5450200 | ZNF genes & repeats | Gastric | stomach |
9 | chr8:5454800-5457200 | Enhancers | Fetal Brain Male | brain |
10 | chr8:5457000-5458000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr8:5457600-5458000 | Enhancers | Spleen | Spleen |
12 | chr8:5460800-5461200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr8:5461600-5462400 | Enhancers | Brain Germinal Matrix | brain |
14 | chr8:5461600-5462600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr8:5462600-5468200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr8:5464600-5465000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr8:5467000-5467800 | Enhancers | Brain Substantia Nigra | brain |
18 | chr8:5468200-5469600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr8:5468800-5469400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr8:5469000-5469400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr8:5469000-5469400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
22 | chr8:5469000-5469400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
23 | chr8:5469200-5469600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
24 | chr8:5469400-5472400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
25 | chr8:5470000-5470200 | Enhancers | Pancreas | Pancrea |
26 | chr8:5471800-5472800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
27 | chr8:5472400-5472800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
28 | chr8:5472600-5476200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
29 | chr8:5472800-5476800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |